J. Alexander's Holdings Inc C (JAX)

14  +0.02 (+0.14%)

After market: 14 0 (0%)

Fundamental Rating

1

Overall JAX gets a fundamental rating of 1 out of 10. We evaluated JAX against 135 industry peers in the Hotels, Restaurants & Leisure industry. JAX may be in some trouble as it scores bad on both profitability and health. JAX has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

In the past year JAX was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 3.15%
ROE 6.69%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 2.56%
PM (TTM) 3.48%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

JAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 2.00 indicates that JAX is not a great score, but indicates only limited risk for bankruptcy at the moment.
JAX has a Debt/Equity ratio of 0.77. This is a neutral value indicating JAX is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF N/A
Altman-Z 2
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.20 indicates that JAX should not have too much problems paying its short term obligations.
JAX has a Quick Ratio of 1.10. This is a normal value and indicates that JAX is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.1

3

3. Growth

3.1 Past

The earnings per share for JAX have decreased strongly by -17.28% in the last year.
The Earnings Per Share has been growing by 12.12% on average over the past years. This is quite good.
The Revenue has grown by 9.47% in the past year. This is quite good.
The Revenue has been decreasing by -3.39% on average over the past years.
EPS 1Y (TTM)-17.28%
EPS 3Y16.47%
EPS 5Y12.12%
EPS growth Q2Q-21.05%
Revenue 1Y (TTM)9.47%
Revenue growth 3Y-7.71%
Revenue growth 5Y-3.39%
Revenue growth Q2Q146.72%

3.2 Future

JAX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.40% yearly.
Based on estimates for the next years, JAX will show a small growth in Revenue. The Revenue will grow by 1.87% on average per year.
EPS Next Y11.1%
EPS Next 2Y5.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.2%
Revenue Next 2Y1.87%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.90, the valuation of JAX can be described as rather expensive.
The average S&P500 Price/Earnings ratio is at 24.84. JAX is around the same levels.
With a Price/Forward Earnings ratio of 15.95, JAX is valued correctly.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.35, JAX is valued a bit cheaper.
Industry RankSector Rank
PE 20.9
Fwd PE 15.95

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.79

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates JAX does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)1.88
PEG (5Y)1.72
EPS Next 2Y5.4%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

JAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

J. Alexander's Holdings Inc C

NYSE:JAX (9/29/2021, 7:04:00 PM)

After market: 14 0 (0%)

14

+0.02 (+0.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap211.12M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 20.9
Fwd PE 15.95
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.88
PEG (5Y)1.72
Profitability
Industry RankSector Rank
ROA 3.15%
ROE 6.69%
ROCE
ROIC
ROICexc
ROICexgc
OM 2.56%
PM (TTM) 3.48%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.2
Quick Ratio 1.1
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-17.28%
EPS 3Y16.47%
EPS 5Y
EPS growth Q2Q
EPS Next Y11.1%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.47%
Revenue growth 3Y-7.71%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y